Hoechst Marion Roussel Inc.
Hoechst Marion Roussel Inc. was acquired by Aventis Pharmaceuticals Inc. Hoechst Marion Roussel Inc. discovers, develops, manufactures, and sells proprietary and generic pharmaceutical products. These products were marketed through programs targeted to reach medical and health care professionals, managed health care providers, institutions, and pharmacies primarily in the United States, Australia/New Zealand, Canada, France, Germany, Italy, Japan, Spain, and the United Kingdom, as well as in other countries. The company was formerly known as Marion Merrell Dow, Inc. and changed its name to Hoechst Marion Roussel Inc. in 1995. Hoechst Marion Roussel Inc. was founded in 1964 and is based in Kansas City, Missouri.
Market Cap
$7.1B
Volume
538.0K
Cash and Equivalents
$120.0M
EBITDA
$710.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.1B
Profit Margin
67.95%
52 Week High
$27.38
52 Week Low
$19.00
Dividend
N/A
Price / Book Value
3.29
Price / Earnings
17.01
Price / Tangible Book Value
5.56
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$592.0M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$561.0M
Debt
$102.0M
Equity
$2.3B
Revenue
$3.1B
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick PremiumCompany Stock Pitches
No stock pitches match your current filters.
Try adjusting your filters or clearing them and trying again.